InMed Pharmaceuticals Inc. (NASDAQ: INM) (‘InMed’ or the ‘Company’), a pharmaceutical company focused on developing…
Editor's Pick
View AllThe US government has entered into an US$80 billion partnership with Brookfield Asset Management (NYSE:BAM,TSX:BAM)…